Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 22615

1.

Rationale and design of the RT-AF study: Combination of Rivaroxaban and Ticagrelor in Patients with Atrial Fibrillation and Coronary Artery Disease undergoing Percutaneous Coronary Intervention.

Gao F, Shen H, Wang ZJ, Yang SW, Liu XL, Zhou YJ.

Contemp Clin Trials. 2015 May 20. pii: S1551-7144(15)30011-2. doi: 10.1016/j.cct.2015.05.012. [Epub ahead of print]

PMID:
26003433
2.

Incidence and cost of medications dispensed despite electronic medical record discontinuation.

Baranowski PJ, Peterson KL, Statz-Paynter JL, Zorek JA.

J Am Pharm Assoc (2003). 2015 May 1;55(3):313-319. doi: 10.1331/JAPhA.2015.14154.

PMID:
26003160
3.

Management and outcome of major bleeding in patients on triple therapy after coronary stenting. Clues from the WARfarin and coronary STENTing (WAR-STENT) registry.

Rubboli A, Calabrò P, Saia F, Sciahbasi A; WARfarin and coronary STENTing (WAR-STENT) Study Group.

J Cardiovasc Med (Hagerstown). 2015 May 21. [Epub ahead of print] No abstract available.

PMID:
26002833
4.

Pulmonary arteriovenous malformation as a cause of embolic stroke: case report and review of the literature.

Anticoli S, Pezzella FR, Siniscalchi A, Gallelli L, Bravi MC.

Interv Neurol. 2015 Jan;3(1):27-30. doi: 10.1159/000368969.

PMID:
25999989
5.
6.

Atrial fibrillation in amyloidotic cardiomyopathy: prevalence, incidence, risk factors and prognostic role.

Longhi S, Quarta CC, Milandri A, Lorenzini M, Gagliardi C, Manuzzi L, Bacchi-Reggiani ML, Leone O, Ferlini A, Russo A, Gallelli I, Rapezzi C.

Amyloid. 2015 May 21:1-9. [Epub ahead of print]

PMID:
25997105
7.

Risk of gastrointestinal adverse effects of dabigatran compared with warfarin among patients with atrial fibrillation: a nationwide cohort study.

Staerk L, Gislason GH, Lip GY, Fosbøl EL, Hansen ML, Lamberts M, Bonde AN, Torp-Pedersen C, Olesen JB.

Europace. 2015 May 19. pii: euv119. [Epub ahead of print]

PMID:
25995392
8.

Identification and Functional Assessment of a New CYP2C9 Allelic Variant CYP2C9*59.

Dai DP, Wang SH, Li CB, Geng PW, Cai J, Wang H, Hu GX, Cai JP.

Drug Metab Dispos. 2015 May 20. pii: dmd.115.063412. [Epub ahead of print]

PMID:
25994031
9.

Real-World Medical Cost Avoidance When New Oral Anticoagulants are Used Versus Warfarin for Venous Thromboembolism in the United States.

Amin A, Bruno A, Trocio J, Lin J, Lingohr-Smith M.

Clin Appl Thromb Hemost. 2015 May 19. pii: 1076029615585991. [Epub ahead of print]

PMID:
25993994
10.

Assessing the potential adoption and usefulness of concurrent, action-oriented, electronic adverse drug event triggers designed for the outpatient setting.

Mull HJ, Rosen AK, Shimada SL, Rivard PE, Nordberg B, Long B, Hoffman JM, Leecaster M, Savitz LA, Shanahan CW, Helwig A, Nebeker JR.

EGEMS (Wash DC). 2015 Apr 30;3(1):1116. doi: 10.13063/2327-9214.1116. eCollection 2015.

11.

Self-management of warfarin therapy.

Sølvik UØ, Løkkebø ES, Kristoffersen AH, Stavelin AV, Binder S, Sandberg S.

Tidsskr Nor Laegeforen. 2015 May 19;135(9):849-853. eCollection 2015 May. English, Norwegian. No abstract available.

12.

Impact of pharmacist-managed warfarin on patient outcomes in an academic medical center.

Martin CY, Hermann SA, Couldry RJ.

Am J Health Syst Pharm. 2015 Jun 1;72(11 Suppl 1):S31. doi: 10.2146/sp150008. No abstract available.

PMID:
25991591
13.

Clinical Application of Genotype-guided Dosing of Warfarin in Patients with Acute Stroke.

Šupe S, Poljaković Z, Božina T, Ljevak J, Macolić Šarinić V, Božina N.

Arch Med Res. 2015 May 16. pii: S0188-4409(15)00102-2. doi: 10.1016/j.arcmed.2015.05.001. [Epub ahead of print]

PMID:
25989350
14.

Endovascular treatment and the outcomes of atherosclerotic intracranial stenosis in patients with hyperacute stroke.

Yoon W, Kim SK, Park MS, Kim BC, Kang HK.

Neurosurgery. 2015 Jun;76(6):680-6. doi: 10.1227/NEU.0000000000000694.

PMID:
25988927
15.

Stroke prevention in atrial fibrillation: a systematic review.

Lip GY, Lane DA.

JAMA. 2015 May 19;313(19):1950-62. doi: 10.1001/jama.2015.4369. Review.

PMID:
25988464
16.

Coagulation assessment with the new generation of oral anticoagulants.

Pollack CV Jr.

Emerg Med J. 2015 May 18. pii: emermed-2015-204891. doi: 10.1136/emermed-2015-204891. [Epub ahead of print] Review.

17.

Axillary vein thrombosis induced by an increasingly popular oscillating dumbbell exercise device: a case report.

Shennib H, Hickle K, Bowles B.

J Cardiothorac Surg. 2015 May 20;10(1):73. [Epub ahead of print]

18.

Feasibility and safety of uninterrupted dabigatran therapy in patients undergoing ablation for atrial fibrillation.

Nagao T, Inden Y, Shimano M, Fujita M, Yanagisawa S, Kato H, Ishikawa S, Miyoshi A, Okumura S, Ohguchi S, Yamamoto T, Yoshida N, Hirai M, Murohara T.

Intern Med. 2015;54(10):1167-73. doi: 10.2169/internalmedicine.54.3520. Epub 2015 May 15.

19.

Warfarin Metabolites in Patients Following Cardiac Valve Implantation: A Contribution of Clinical and Genetic Factors.

Bryk A, Wypasek E, Awsiuk M, Maj D, Undas A.

Cardiovasc Drugs Ther. 2015 May 19. [Epub ahead of print]

PMID:
25986145
20.

Low-Dose 3-Factor Prothrombin Complex Concentrate for Warfarin Reversal Prior to Heart Transplant.

Kantorovich A, Fink JM, Militello MA, Wanek MR, Smedira NG, Soltesz EG, Moazami N.

Ann Pharmacother. 2015 May 18. pii: 1060028015585344. [Epub ahead of print]

PMID:
25986007
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk